State Of Wyoming Selecta Biosciences Inc Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.04 - $1.4 $5,980 - $8,049	5,750 Added 32.93%	23,210 $25,000
Q1 2023 May 12, 2023	SELL	$1.15 - $1.89 $37,812 - $62,143	-32,880 Reduced 65.32%	17,460 $24,000
Q4 2022 Feb 14, 2023	BUY	$0.96 - $1.6 $35,692 - $59,488	37,180 Added 282.52%	50,340 $56,000
Q3 2022 Nov 14, 2022	SELL	$1.33 - $2.6 $15,162 - $29,640	-11,400 Reduced 46.42%	13,160 $22,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $1.4 $13,032 - $27,232	19,452 Added 380.81%	24,560 $32,000
Q1 2022 May 13, 2022	SELL	$1.23 - $3.31 $27,761 - $74,706	-22,570 Reduced 81.54%	5,108 $6,000
Q4 2021 Feb 11, 2022	BUY	$2.89 - $4.43 $79,989 - $122,613	27,678 New	27,678 $90,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.